搜索
Unicycive Therapeutics Inc
UNCY添加自选
5.010USD
-0.290-5.47%
收盘 07-31 16:00（美东）报价延迟15分钟
133.77M总市值
亏损市盈率 TTM
关于 Unicycive Therapeutics Inc 公司
Unicycive Therapeutics, Inc. is a biotechnology company developing treatments for kidney diseases. The Company's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.
Unicycive Therapeutics Inc简介
公司代码UNCY
公司名称Unicycive Therapeutics Inc
上市日期Jun 17, 2021
CEOGupta (Shalabh)
员工数量22
证券类型Ordinary Share
年结日Jun 17
公司地址4300 El Camino Real, Suite 210
城市LOS ALTOS
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94022
电话16503840642
网址https://unicycive.com/
公司代码UNCY
上市日期Jun 17, 2021
CEOGupta (Shalabh)
Unicycive Therapeutics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Sandeep (Steve) Laumas, M.D.
Dr. Sandeep (Steve) Laumas, M.D.
Independent Director
Independent Director
10.58K
+0.01%
Dr. Pramod Gupta, Ph.D.
Dr. Pramod Gupta, Ph.D.
Executive Vice President - Pharmaceutical and Business Operations
Executive Vice President - Pharmaceutical and Business Operations
4.18K
--
Dr. Shalabh Gupta, M.D.
Dr. Shalabh Gupta, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. John Townsend
Mr. John Townsend
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gaurav Aggarwal, M.D.
Dr. Gaurav Aggarwal, M.D.
Independent Director
Independent Director
--
--
Mr. Doug Jermasek
Mr. Doug Jermasek
Executive Vice President - Corporate Strategy
Executive Vice President - Corporate Strategy
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Sandeep (Steve) Laumas, M.D.
Dr. Sandeep (Steve) Laumas, M.D.
Independent Director
Independent Director
10.58K
+0.01%
Dr. Pramod Gupta, Ph.D.
Dr. Pramod Gupta, Ph.D.
Executive Vice President - Pharmaceutical and Business Operations
Executive Vice President - Pharmaceutical and Business Operations
4.18K
--
Dr. Shalabh Gupta, M.D.
Dr. Shalabh Gupta, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. John Townsend
Mr. John Townsend
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gaurav Aggarwal, M.D.
Dr. Gaurav Aggarwal, M.D.
Independent Director
Independent Director
--
--
常见问题
Unicycive Therapeutics Inc的前五大股东是谁？
Unicycive Therapeutics Inc 的前五大股东如下：Dr. Sandeep (Steve) Laumas, M.D.
有多少机构持有Unicycive Therapeutics Inc(UNCY)的股份？
截至2026Q1，共有75家机构持有Unicycive Therapeutics Inc的股份，合计持有的股份价值约为9.56M，占公司总股份的35.81%。与2025Q4相比，机构持股有所增加，增幅为450872.00。